+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac Rhythm Management Devices Market Size, Share & Trends Analysis Report by Products (Pacemakers (Implantable, External), Defibrillators, Cardiac Resynchronization Therapy), Region, and Segment Forecasts, 2025-2030

  • PDF Icon

    Report

  • 150 Pages
  • October 2024
  • Region: Global
  • Grand View Research
  • ID: 4479740
The global cardiac rhythm management devices market size is anticipated to reach USD 24.8 billion in 2030 and is projected to grow at a CAGR of 6.4% from 2025 to 2030. The key factors driving the market include growth in the adoption of cardiac rhythm management (CRM) devices owing to the increasing prevalence of cardiovascular disorders. According to the Centers for Disease Control and Prevention (CDC), as of September 2021, approximately 659,000 Americans die suffering from heart disease every year. The market was negatively impacted during the COVID-19 pandemic, as elective procedures, including the non-essential cardiovascular procedures, were postponed or canceled during the pandemic.

Major players in the market such as Medtronic; Abbott; and Boston Scientific Corporation, incurred huge losses in their cardiac rhythm management business segments globally. This resulted in negative growth of the market in 2020. The rising demand for handling sudden cardiac arrests is leading to innovation in all types of cardiac rhythm management devices. Innovation with regards to implantable devices includes products, such as subcutaneous and transvenous devices, that aim to increase the comfort level of patients. Swedish Transport Agency ran a program under the test phase, which aimed to deliver AEDs using a drone. This may reduce the delivery time of an AED, increasing the chances of survival with faster treatment.

Therefore, the market is anticipated to grow because of technological advancements and product innovations. Revolutionary technological signs of progress are rapidly transforming the market. These expansions are producing lucrative potentials. An increase in R&D expenditure and new product launches by leading firms further fueled the growth. For instance, in October 2020, Abbott launched its new ICD and CRT-D in India, hence expanding its product portfolio in the country. The company had also received CE Mark approval for its Gallant ICD and CRT-D devices in February 2020. Such factors boost market growth. Key market players account for a significant share of the market owing to their extensive product offerings.

Cardiac Rhythm Management Devices Market Report Highlights

  • By product, defibrillators dominated the market with a share of over 44.9% in 2024 due to their high adoption globally.
  • In the external defibrillator segment, the automatic external defibrillator segment held the highest revenue share owing to associated benefits, including pacing, i.e., delivering pulses of the current to stimulate heart contraction as well as cardioversion, converting arrhythmia or tachycardia to a normal heartbeat.
  • In 2024, North America held the dominant share of the market owing to the rising prevalence of cardiovascular diseases and high adoption of CRM devices.
  • Asia Pacific region is expected to show lucrative growth over the forecast period owing to the presence of emerging countries such as China and India.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments
  • Competitive Landscape: Explore the market presence of key players worldwide
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

The leading players in the Cardiac Rhythm Management Devices market include:

  • Physio-Control, Inc.
  • Medtronic, plc
  • ABBOTT
  • Boston Scientific Corporation
  • Schiller
  • Koninklijke Philips N.V
  • Biotronik
  • Progetti Srl
  • Zoll Medical Corporation
  • LivaNova Plc


This product will be delivered within 2 business days.

Table of Contents

Chapter 1. Methodology And Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.1.1.1. Product Segment
1.2. Regional Scope
1.3. Estimates And Forecast Timeline
1.4. Objectives
1.4.1. Objective - 1
1.4.2. Objective - 2
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information Or Data Analysis
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Primary Sources
1.11. List of Abbreviations
Chapter 2. Cardiac Rhythm Management Devices Market: Executive Summary
2.1. Market Snapshot
2.2. Product Snapshots
2.3. Competitive Landscape Snapshot
Chapter 3. Cardiac Rhythm Management Devices Market Variables, Trends, & Scope
3.1. Market Segmentation And Scope
3.2. Market Lineage Outlook
3.2.1. Parent Market Outlook
3.2.2. Related/Ancillary Market Outlook
3.3. Market Dynamics
3.4. Market Drivers Analysis
3.4.1. Growing prevalence of cardiovascular disease
3.4.2. Increasing preference for minimally invasive procedures
3.5. Market Restraint Analysis
3.5.1. High cost associated with the devices
3.6. Cardiac Rhythm Management Devices Market Analysis Tools
3.6.1. Industry Analysis - Porter’s
3.6.1.1. Supplier Power
3.6.1.2. Buyer Power
3.6.1.3. Substitution Threat
3.6.1.4. Threat Of New Entrant
3.6.1.5. Competitive Rivalry
3.6.2. PESTLE Analysis
3.6.2.1. Political Landscape
3.6.2.2. Technological Landscape
3.6.2.3. Economic Landscape
3.6.3. Pricing Analysis
Chapter 4. Cardiac Rhythm Management Devices: Product Estimates & Trend Analysis
4.1. Product Market Share, 2024 & 2030
4.2. Segment Dashboard
4.3. Global Cardiac Rhythm Management Devices Market By Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 To 2030 For the Following
4.4.1. Pacemakers
4.4.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.1.1.1. Implantable
4.4.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.1.1.2. External
4.4.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.2. Defibrillators
4.4.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.2.1.1. Implantable Cardioverter Defibrillators (ICD)
4.4.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.2.1.1.1.1. S-ICD
4.4.2.1.1.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.2.1.1.1.2. T-ICD
4.4.2.1.1.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.2.1.2. External Defibrillator
4.4.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.2.1.2.1.1. Manual External Defibrillator
4.4.2.1.2.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.2.1.2.1.2. Automatic External Defibrillator
4.4.2.1.2.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.2.1.2.1.3. Wearable Cardioverter Defibrillator
4.4.2.1.2.1.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.3. Cardiac Resynchronization Therapy (CRT)
4.4.3.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.3.1.1. CRT-Defibrillator
4.4.3.1.1.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
4.4.3.1.2. CRT-Pacemakers
4.4.3.1.2.1. Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 5. Regional Business Analysis
5.1. Regional Market Share Analysis, 2024 & 2030
5.2. Regional Market Dashboard
5.3. Global Regional Market Snapshot
5.4. Marker Size, & Forecasts Trend Analysis, 2018 To 2030:
5.5. North America
5.5.1. U.S.
5.5.1.1. Key Country Dynamics
5.5.1.2. Competitive Scenario
5.5.1.3. Regulatory Framework
5.5.1.4. U.S. Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.5.2. Canada
5.5.2.1. Key Country Dynamics
5.5.2.2. Competitive Scenario
5.5.2.3. Regulatory Framework
5.5.2.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.5.3. Mexico
5.5.3.1. Key Country Dynamics
5.5.3.2. Competitive Scenario
5.5.3.3. Regulatory Framework
5.5.3.4. Canada Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.6. Europe
5.6.1. UK
5.6.1.1. Key Country Dynamics
5.6.1.2. Competitive Scenario
5.6.1.3. Regulatory Framework
5.6.1.4. UK Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.6.2. Germany
5.6.2.1. Key Country Dynamics
5.6.2.2. Competitive Scenario
5.6.2.3. Regulatory Framework
5.6.2.4. Germany Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.6.3. Spain
5.6.3.1. Key Country Dynamics
5.6.3.2. Competitive Scenario
5.6.3.3. Regulatory Framework
5.6.3.4. Spain Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.6.4. France
5.6.4.1. Key Country Dynamics
5.6.4.2. Competitive Scenario
5.6.4.3. Regulatory Framework
5.6.4.4. France Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.6.5. Italy
5.6.5.1. Key Country Dynamics
5.6.5.2. Competitive Scenario
5.6.5.3. Regulatory Framework
5.6.5.4. Italy Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.6.6. Denmark
5.6.6.1. Key Country Dynamics
5.6.6.2. Competitive Scenario
5.6.6.3. Regulatory Framework
5.6.6.4. Denmark Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.6.7. Sweden
5.6.7.1. Key Country Dynamics
5.6.7.2. Competitive Scenario
5.6.7.3. Regulatory Framework
5.6.7.4. Sweden Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.6.8. Norway
5.6.8.1. Key Country Dynamics
5.6.8.2. Competitive Scenario
5.6.8.3. Regulatory Framework
5.6.8.4. Norway Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.7. Asia Pacific
5.7.1. Japan
5.7.1.1. Key Country Dynamics
5.7.1.2. Competitive Scenario
5.7.1.3. Regulatory Framework
5.7.1.4. Japan Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.7.2. China
5.7.2.1. Key Country Dynamics
5.7.2.2. Competitive Scenario
5.7.2.3. Regulatory Framework
5.7.2.4. China Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.7.3. India
5.7.3.1. Key Country Dynamics
5.7.3.2. Competitive Scenario
5.7.3.3. Regulatory Framework
5.7.3.4. India Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.7.4. South Korea
5.7.4.1. Key Country Dynamics
5.7.4.2. Competitive Scenario
5.7.4.3. Regulatory Framework
5.7.4.4. South Korea Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.7.5. Thailand
5.7.5.1. Key Country Dynamics
5.7.5.2. Competitive Scenario
5.7.5.3. Regulatory Framework
5.7.5.4. Thailand Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.7.6. Australia
5.7.6.1. Key Country Dynamics
5.7.6.2. Competitive Scenario
5.7.6.3. Regulatory Framework
5.7.6.4. Australia Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.8. Latin America
5.8.1. Brazil
5.8.1.1. Key Country Dynamics
5.8.1.2. Competitive Scenario
5.8.1.3. Regulatory Framework
5.8.1.4. Brazil Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.8.2. Argentina
5.8.2.1. Key Country Dynamics
5.8.2.2. Competitive Scenario
5.8.2.3. Regulatory Framework
5.8.2.4. Argentina Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.9. MEA
5.9.1. MEA Cardiac Rhythm Management Devices Market, 2018 - 2030 (USD Million)
5.9.2. South Africa
5.9.2.1. Key Country Dynamics
5.9.2.2. Competitive Scenario
5.9.2.3. Regulatory Framework
5.9.2.4. South Africa Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.9.3. Saudi Arabia
5.9.3.1. Key Country Dynamics
5.9.3.2. Competitive Scenario
5.9.3.3. Regulatory Framework
5.9.3.4. Saudi Arabia Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.9.4. UAE
5.9.4.1. Key Country Dynamics
5.9.4.2. Competitive Scenario
5.9.4.3. Regulatory Framework
5.9.4.4. UAE Market Estimates and Forecasts 2018 To 2030 (USD Million)
5.9.5. Kuwait
5.9.5.1. Key Country Dynamics
5.9.5.2. Competitive Scenario
5.9.5.3. Regulatory Framework
5.9.5.4. Kuwait Market Estimates and Forecasts 2018 To 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, By Key Market Participants
6.2. Company /Competition Categorization
6.3. Vendor Landscape
6.3.1. List of Key Distributors And Channel Partners
6.3.2. Key Customers
6.3.3. Key Company Market Share Analysis, 2023
6.3.4. Physio-Control, Inc.
6.3.4.1. Overview
6.3.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.4.3. Product Benchmarking
6.3.4.4. Strategic Initiatives
6.3.5. Medtronic, plc
6.3.5.1. Overview
6.3.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.5.3. Product Benchmarking
6.3.5.4. Strategic Initiatives
6.3.6. ABBOTT
6.3.6.1. Overview
6.3.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.6.3. Product Benchmarking
6.3.6.4. Strategic Initiatives
6.3.7. Boston Scientific Corporation
6.3.7.1. Overview
6.3.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.7.3. Product Benchmarking
6.3.7.4. Strategic Initiatives
6.3.8. Schiller
6.3.8.1. Overview
6.3.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.8.3. Product Benchmarking
6.3.8.4. Strategic Initiatives
6.3.9. Koninklijke Philips N.V
6.3.9.1. Overview
6.3.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.9.3. Product Benchmarking
6.3.9.4. Strategic Initiatives
6.3.10. Biotronik
6.3.10.1. Overview
6.3.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.10.3. Product Benchmarking
6.3.10.4. Strategic Initiatives
6.3.11. Progetti Srl
6.3.11.1. Overview
6.3.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.11.3. Product Benchmarking
6.3.11.4. Strategic Initiatives
6.3.12. Zoll Medical Corporation
6.3.12.1. Overview
6.3.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.12.3. Product Benchmarking
6.3.12.4. Strategic Initiatives
6.3.13. LivaNova Plc
6.3.13.1. Overview
6.3.13.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
6.3.13.3. Product Benchmarking
6.3.13.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviations
Table 2 North America Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
Table 3 North America Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 4 U.S. Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 5 Canada Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 6 Mexico Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 7 Europe Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
Table 8 Europe Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 9 UK Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 10 Germany Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 11 France Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 12 Italy Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 13 Spain Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 14 Sweden Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 15 Norway Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 16 Denmark Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 17 Asia Pacific Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
Table 18 Asia Pacific Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 19 Japan Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 20 China Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 21 India Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 22 Australia Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 23 South Korea Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 24 Thailand Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 25 Latin America Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
Table 26 Latin America Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 27 Brazil Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 28 Argentina Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 29 MEA Cardiac Rhythm Management Devices Market, Region, 2018 - 2030 (USD Million)
Table 30 MEA Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 31 South Africa Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 32 Saudi Arabia Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 33 UAE Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
Table 34 Kuwait Cardiac Rhythm Management Devices Market, By Product, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market Research Process
Fig. 2 Data Triangulation Techniques
Fig. 3 Primary Research Pattern
Fig. 4 Primary Interviews in North America
Fig. 5 Primary Interviews in Europe
Fig. 6 Primary Interviews in APAC
Fig. 7 Primary Interviews in Latin America
Fig. 8 Primary Interviews in MEA
Fig. 9 Market Research Approaches
Fig. 10 Value-chain-based Sizing & Forecasting
Fig. 11 QFD Modeling for Market Share Assessment
Fig. 12 Market Formulation & Validation
Fig. 13 Cardiac Rhythm Management Devices Market: Market Outlook
Fig. 14 Cardiac Rhythm Management Devices Competitive Insights
Fig. 15 Parent Market Outlook
Fig. 16 Related/Ancillary Market Outlook
Fig. 17 Penetration And Growth Prospect Mapping
Fig. 18 Industry Value Chain Analysis
Fig. 19 Cardiac Rhythm Management Devices Market Driver Impact
Fig. 20 Cardiac Rhythm Management Devices Market Restraint Impact
Fig. 21 Cardiac Rhythm Management Devices Market Strategic Initiatives Analysis
Fig. 22 Cardiac Rhythm Management Devices Market: Product Movement Analysis
Fig. 23 Cardiac Rhythm Management Devices Market: Product Outlook and Key Takeaways
Fig. 24 Pacemakers Market Estimates and Forecast, 2018 - 2030
Fig. 25 Defibrillators Market Estimates and Forecast, 2018 - 2030
Fig. 26 Cardiac Resynchronization Therapy (CRT) Market Estimates and Forecast, 2018 - 2030
Fig. 27 Global Cardiac Rhythm Management Devices Market: Regional Movement Analysis
Fig. 28 Global Cardiac Rhythm Management Devices Market: Regional Outlook and Key Takeaways
Fig. 29 Global Cardiac Rhythm Management Devices Market Share and Leading Players
Fig. 30 North America Market Share and Leading Players
Fig. 31 Europe Market Share and Leading Players
Fig. 32 Asia Pacific Market Share and Leading Players
Fig. 33 Latin America Market Share and Leading Players
Fig. 34 Middle East & Africa Market Share and Leading Players
Fig. 35 North America, By Country
Fig. 36 North America
Fig. 37 North America Market Estimates and Forecasts, 2018 - 2030
Fig. 38 U.S.
Fig. 39 U.S. Market Estimates and Forecasts, 2018 - 2030
Fig. 40 Canada
Fig. 41 Canada Market Estimates and Forecasts, 2018 - 2030
Fig. 42 Mexico
Fig. 43 Mexico Market Estimates and Forecasts, 2018 - 2030
Fig. 44 Europe
Fig. 45 Europe Market Estimates and Forecasts, 2018 - 2030
Fig. 46 UK
Fig. 47 UK Market Estimates and Forecasts, 2018 - 2030
Fig. 48 Germany
Fig. 49 Germany Market Estimates and Forecasts, 2018 - 2030
Fig. 50 France
Fig. 51 France Market Estimates and Forecasts, 2018 - 2030
Fig. 52 Italy
Fig. 53 Italy Market Estimates and Forecasts, 2018 - 2030
Fig. 54 Spain
Fig. 55 Spain Market Estimates and Forecasts, 2018 - 2030
Fig. 56 Denmark
Fig. 57 Denmark Market Estimates and Forecasts, 2018 - 2030
Fig. 58 Sweden
Fig. 59 Sweden Market Estimates and Forecasts, 2018 - 2030
Fig. 60 Norway
Fig. 61 Norway Market Estimates and Forecasts, 2018 - 2030
Fig. 62 Asia Pacific
Fig. 63 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
Fig. 64 China
Fig. 65 China Market Estimates and Forecasts, 2018 - 2030
Fig. 66 Japan
Fig. 67 Japan Market Estimates and Forecasts, 2018 - 2030
Fig. 68 India
Fig. 69 India Market Estimates and Forecasts, 2018 - 2030
Fig. 70 Thailand
Fig. 71 Thailand Market Estimates and Forecasts, 2018 - 2030
Fig. 72 South Korea
Fig. 73 South Korea Market Estimates and Forecasts, 2018 - 2030
Fig. 74 Australia
Fig. 75 Australia Market Estimates and Forecasts, 2018 - 2030
Fig. 76 Latin America
Fig. 77 Latin America Market Estimates and Forecasts, 2018 - 2030
Fig. 78 Brazil
Fig. 79 Brazil Market Estimates and Forecasts, 2018 - 2030
Fig. 80 Argentina
Fig. 81 Argentina Market Estimates and Forecasts, 2018 - 2030
Fig. 82 Middle East and Africa
Fig. 83 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
Fig. 84 South Africa
Fig. 85 South Africa Market Estimates and Forecasts, 2018 - 2030
Fig. 86 Saudi Arabia
Fig. 87 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
Fig. 88 UAE
Fig. 89 UAE Market Estimates and Forecasts, 2018 - 2030
Fig. 90 Kuwait
Fig. 91 Kuwait Market Estimates and Forecasts, 2018 - 2030
Fig. 92 Market Share of Key Market Players- Cardiac Rhythm Management Devices Market

Companies Mentioned

  • Physio-Control, Inc.
  • Medtronic, plc
  • ABBOTT
  • Boston Scientific Corporation
  • Schiller
  • Koninklijke Philips N.V
  • Biotronik
  • Progetti Srl
  • Zoll Medical Corporation
  • LivaNova Plc

Methodology

Loading
LOADING...

Table Information